The increasing issue of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a significant challenge to global public health and law enforcement. These substances, frequently synthesized to circumvent existing website drug laws, quickly appear on the scene and are marketed as "legal highs" or "research chemicals," tempting i